The respiratory tract is normally kept essentially free of bacteria by cilia-mediated mucus transport, but in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) mucus accumulates due to goblet cell hyperplasia and mucin overexpression. To address mechanisms behind the mucus accumulation, the elastase-induced mouse model was utilized. The proteomes of bronchoalveolar lavage fluid from elastase-induced mice and COPD patients showed similarities to each other and to colonic mucus. Lung mucus showed a striated, laminated appearance in the elastase-induced mice, COPD and CF, resembling that observed for colonic mucus. Less mucus obstruction was observed in mice lacking the Muc5b mucin. The accumulated mucus plugs of the elastase-induced mice were possible to wash out, but a mucus layer covering the epithelium remained attached to the surface goblet cells also after hypertonic saline washings as widely used in CF therapy. The results suggest that the lung can convert its mucus system into an attached mucus layer that protects the epithelium, similarly to the colon.
Introduction
Stagnant mucus is a problem in several airway diseases including chronic obstructive pulmonary disease (COPD) (Smaldone et al., 1993) , cystic fibrosis (CF) (Regnis et al., 1994) , and asthma (Bateman et al., 1983) . COPD is a global health issue estimated to be the third leading cause of death worldwide in 2020 and the disease is an increasing economic and personal burden. It is characterized by restricted airflow and progressive loss of lung function and encompasses two major phenotypes, chronic bronchitis and emphysema, both caused by excessive inflammatory response to environmental noxious insults. Chronic bronchitis involves an increase in goblet cell number, enlarged submucosal glands, mucus hypersecretion, mucus plugging of the airways, and chronic cough (Vestbo et al., 2013) . Even COPD patients without chronic bronchitis have mucus obstruction of the small airways (Hogg et al., 2004) .
The mucociliary system keeps the respiratory tract low in bacteria and removes any inhaled particulate matter. Healthy mucus traps bacteria and particles that the mucus transports up to the larynx resulting in efficient cleaning. In numerous lung diseases, including COPD and CF, mucus stagnates and accumulates in the airways, leading to bacterial colonization, airway inflammation, tissue destruction, and ultimately respiratory failure. Mechanisms of mucociliary dysfunction include the aberrant overproduction of mucus components leading to accumulation on the airway surfaces. Mucus is made up by many different components, but mucins are the major macromolecular constituents. In human and pig airways, there are two major gel-forming mucins, the MUC5B from the glands and the MUC5AC from the surface goblet cells. The glands form MUC5B mucin bundles that under normal conditions sweep the tracheobronchial surface to remove debris and bacteria (Ermund et al., 2017) . In rodents, which lack submucosal glands, both Muc5b and Muc5ac mucins are made by the surface goblet cells. Also in rodents, the Muc5b mucin is essential for keeping the mouse lungs clean under normal conditions (Roy et al., 2014) .
There are several rodent models of chronic airway disease. For example, models induced by ovalbumin (Kung et al., 1994) , IL-13 (Kuperman et al., 2002) , LPS instillation, or cigarette smoke (Shapiro, 2000) are used. Airway instillation of various forms of elastase, for example neutrophil elastase or porcine pancreatic elastase (PPE), in mice, rats, guinea pigs, dogs or ferrets has been widely used as models of COPD and emphysema (Conlon et al., 2016; Gross et al., 1964) . This can also be extended to CF since neutrophils accumulate in CF lungs (Birrer et al., 1994) . Based on the importance of elastase in chronic lung diseases and the fast onset of goblet cell hyperplasia we focused on the elastase model. PPE is instilled intranasally twice with a 7 day interval and animals analyzed two weeks after the first instillation. We have analyzed this model for goblet cell hyperplasia, mucus accumulation, inflammation, and mucus proteins and compared the mucus proteome to human airway disease and colon mucus. The importance of the Muc5ac and Muc5b mucins were addressed by using knockout mice. We tested a common treatment for mucus accumulation in the airways, hypertonic saline, and its ability to detach the accumulated mucus. Collectively, our results show a striking similarity between the accumulated mucus in the respiratory tract of mice and COPD patients with that of the gastrointestinal tract.
Results

PPE treatment causes goblet cell hyperplasia and airway plugging.
Mice intranasally exposed to saline largely lacked Alcian blue/Periodic acid-Schiff (AB/PAS) positive cells in the airways whereas a marked increase in AB/PAS positive cells within the bronchi and bronchioles was observed in PPE-exposed mice and not after saline-or PPEinactivated treatment (Fig 1A-D, S1 ). Whole mouse lungs stained with AB/PAS showed that the hyperplasia had a patchy distribution, affecting bronchi and proximal bronchioles with both goblet cell hyperplasia and mucus plugging (Fig 1CD) . This was further illustrated by transmission electron microscopy ( Fig S2A) . Histopathology evaluation of inflated lungs from PPE-challenged mice revealed a mild perivascular and peribronchiolar lymphocytic inflammation relative to control mice (Fig 1E, S2B ). These alterations were accompanied by a patchy destruction of the inter-alveolar septa with moderate to severe multi-focal loss of tissue connectivity as in emphysema.Mucus obstruction was quantified in AB/PAS-stained sections, presented as percent airway obstruction, showing a clear increased airway obstruction in PPEexposed mice (Fig 1F) where the smallest airways were more prone to develop severe mucus obstruction ( Fig S3) . Bronchoalveolar lavage fluid (BALF) from PPE-exposed mice showed higher immune cell counts with a 16-fold increase in the total number of white blood cells, consisting of increased amounts of neutrophils, eosinophils, macrophages/monocytes and lymphocytes ( Fig 1G) . The increased number of inflammatory cells was accompanied by increased levels of cytokines, chemo attractants, chemokines, and EGF (Fig S2) . In summary, PPE treatment caused increase in goblet cell numbers, mucus accumulation and immune cell infiltration as in COPD.
Proteome of mouse bronchoalveolar lavage fluid and mucus plugs.
Total BALF samples collected from saline-or PPE-induced mice were analyzed by mass spectrometry based proteomics. To remove cells from BALF, samples were centrifuged and the supernatants analyzed where we observed 349 proteins in controls and 408 in PPE-exposed animals ( Table 1, S1 ). Some of the major proteins including the club cell secreted protein uteroglobin (Scgb1a1), serotransferrin (Tf), and α-1-antitrypsin (Serpin1ad) were common for saline or PPE mice, whereas a relative increase in mucus-related proteins including Clca1, Chitinase-like proteins Chi3l3 and Chi3l4 were observed in the PPE mice (Fig 2AB) . Absolute quantification of the gel-forming mucins Muc5b and Muc5ac corroborated the observed PPE-mediated goblet cell hyperplasia where Muc5ac, not detected in controls, reached concentrations similar to that of Muc5b (Fig 2C, Table S2 ). Muc5b levels were increased 24-fold compared to basal conditions. To better understand the proteins accumulated by PPE, we isolated mucus plugs from BALF after staining with Alcian blue (Fig 2D) . The major components of the airway plugs were similar to those of the BALF, but had an even higher relative level of Clca1 (Fig 2E, Table   1 , S3). In addition, the plugs also contained high proportions of the Bpifb1 (also known as Lplunc1), Muc5ac, Muc5b and Fcgbp. Absolute quantification of Muc5ac and Muc5b in the plugs revealed significantly higher levels of Muc5b relative Muc5ac, in contrast to the BALF were more similar levels were found in PPE-induced mice (Fig 2F) .
Proteome of isolated mouse airway epithelial cells.
To further illustrate the PPE effect, we isolated airway epithelial cells and analyzed their proteome ( Table 1, Table S4 ). The isolation procedure was effective as shown by mouse lung sections stained with H&E before and after epithelial removal (Fig 3A) . Heat map clustering of the proteomic results showed that the epithelial cells of the PPE-exposed mice were clearly separated from the controls with the most noteworthy differences around the Muc5b and Muc5ac nodes (Fig 3B) . Chi3l4 and Clca1 were among the most abundant proteins in PPE-exposed mice (Fig 3CD) . These and the other mucus-related proteins found in PPE-induced BALF and mucus plugs were also increased in epithelial cells, but the chitinase-like proteins were relatively more increased in the PPE-induced epithelial cells (Fig 3E) . Furthermore, the increased levels of immune response proteins in observed in BALF were also found in the epithelial cell fraction (Table S1, S3) . Absolute quantification revealed, in agreement with the BALF, that Muc5ac was only detected after PPE treatment and that Muc5b levels were increased, but in this case only 7.6 times ( Fig 3F) . Muc5b was always more abundant than Muc5ac, in mucus plugs with ratio Muc5ac/Muc5b of 0.3, in BALF supernatant (BALF SN) of 0.7, and in epithelial cells 0.5 ( Fig   3G) .
To support the proteomics and to analyze the tissue localization of key proteins immunostaining was performed (Fig. S4, S5 ). After PPE instillation, Muc5b, Muc5ac, Clca1, and Fcgbp were all found to be increased in the epithelial cells of both bronchi and bronchioles and all these proteins were accumulated in mucus plugs obstructing the airways. The few Muc5ac-positive epithelial cells detected at basal conditions also expressed Muc5b and after PPE a higher proportion of cells co-expressing Muc5ac and Muc5b (Fig S4E) .
Human bronchoalveolar fluid proteome resembles that of the mouse model.
To compare the PPE-induced mouse model with the human disease COPD, we studied human BALF by mass spectrometry based proteomics from never smokers, asymptomatic smokers and COPD patients (Table S5) . Proteomics analysis revealed fewer proteins in the never smokers group as compared to asymptomatic smokers and COPD patients ( Fig 4A, Table S6 ). Principal component analysis showed a tight cluster for the never smokers and a slightly larger for the asymptomatic smokers (Fig 4B) . Interestingly, the COPD patients were distributed over the entire plot suggesting a relatively large variation between the individuals. Absolute quantification of a subset of mucus-related proteins revealed increased amounts of AGR2, DMBT1, FCGBP, PSCA, TFF3, TGM2 and ZG16B in COPD patients and a tendency towards increased levels of these proteins in asymptomatic smokers (Fig 4C, S6 , S7 and Table S7 ). In accordance with the PPE model, MUC5AC and MUC5B were increased in COPD patients and the ratio MUC5AC to MUC5B changed from 0.3 in never smokers to closer to 1.5 in asymptomatic smokers and 0.5 in COPD patients (Fig 4D) . In contrast to the mouse model where Clca1 was one of the most abundant proteins after PPE treatment, CLCA1 was not detected in human BALF. In summary, the human COPD BALF showed large similarities with the PPE mice, although there are some species specific differences.
Airway mucus in elastase-exposed mice, COPD, and CF appeared stratified as in colon.
Tissue fixation using dry Carnoy has been shown to preserve the mucus structure of the intestine (Johansson et al., 2008) . When the PPE-exposed mouse airways were fixed this way and stained by AB/PAS, the mucus in had a stratified, lamellar appearance (Fig 5A) . When mucus was stained with antibodies against Muc5b (green) and Muc5ac (red), the two mucins appeared to form partly separate layers covering the epithelium (Fig 5B) . A stratified mucus appearance was not been observed in control lungs, but resembled the inner mucus layer of the normal mouse distal colon (Fig 5C) . Similar stratified mucus was also observed in lungs from human COPD ( Fig 5D) and CF ( Fig 5D) patients that had undergone lung transplantation. Thus, the mucus accumulated in the PPE model resembled the two chronic lung diseases with an appearance of the mucus similar to the stratified inner colon mucus.
Mucus is anchored to the goblet cells in elastase-exposed mouse airways and cannot be completely washed away.
To analyze if the accumulated mucus was attached to the epithelium in PPE-instilled mouse airways as in the CF mouse ileum (15), we lavaged PPE-exposed lungs twice with PBS. The mucus seemed less dense after this treatment as assessed from Carnoy-fixed tissue sections stained with AB/PAS (Fig 6A) . Using these sections, we analyzed the percentage of total airways that were obstructed by mucus in non-washed and in PBS-lavaged lungs. There was a tendency for less airway obstruction in the PPE-exposed mouse airways after PBS lavage (Fig 6B) . We also estimated the proportion of the airway surface that was covered by mucus without and after washing. As there were essentially no mucus covering the epithelium after saline treatment, there was substantially more epithelial surface covered by mucus in PPE-exposed airways (Fig 6C) .
Interestingly, there was no tendency of the PBS lavage to remove any of the mucus on the surface of PPE-exposed airways.
As the accumulated mucus contained both the Muc5b and Muc5ac mucins, we next addressed the individual importance of these mucins using knockout animals. The Muc5b -/-mice showed significant reduced mucus obstruction whereas the Muc5ac -/-only showed a tendency of reduced mucus obstruction ( Fig 6D) .
We have previously shown that hypertonic saline treatment can detach the abnormally attached mucus of the CF mouse ileum (11) . This treatment is also approved for use in CF patients. To evaluate if hypertonic saline could remove the attached mucus in the PPE-exposed lungs, we instilled 7% hypertonic saline twice into the lungs, left it for 20 min each time, and aspirated the remaining liquid. As a control, we instilled PBS twice for 20 min. The hypertonic saline treatment caused a significant decrease in the percentage of airways that were obstructed by mucus (Fig 6E) . When the percentage of airway surface covered by mucus was evaluated, there was almost no reduced epithelial surface covered by mucus (Fig 6F) . This suggests that the 7% hypertonic saline can remove most of the mucus plugging, but that the surface attached mucus still remained.
To further illustrate how the mucus was attached, we stained Carnoy fixed tissue sections taken after two times 20 min PBS washings with antibodies against Muc5ac and Muc5b and analyzed this by confocal microscopy ( Fig 6G) . The epithelial cell surface was covered by a mucus layer composed of a mixture of the Muc5ac and Muc5b mucins. Both mucins seemed to be retained and anchored in every goblet cell. As it has been proposed that the stagnated lung mucus is attached by entangling into the cilia, we also stained tissue sections for cilia using an anti-tubulin antibody (Fig 6H) . The image shows how the cilia extended in between the Muc5b stained mucus and do not suggest that the cilia were entangled with the mucus. Together these results suggest that the accumulated mucus in the PPE mouse airways is attached to the goblet cells, just as has been observed in the CF mouse intestine (Gustafsson et al., 2012) .
Discussion
Airway diseases such as COPD and CF involve impaired mucociliary clearance which leads to Studies on human BALF samples from COPD patients by proteomic were used to evaluate the similarities with that of the PPE-exposed mouse. Interestingly, principal component analysis of the mass spectrometry results clearly distinguished never smokers, asymptomatic smokers and COPD patients. The never smokers and the asymptomatic smokers clustered well together, whilst the COPD patients spread over the whole graph suggesting a large heterogeneity.
Comparing the absolute amounts of selected proteins, known to be associated with mucus,
showed that all were increased in COPD as compared to never smokers with the asymptomatic smokers in between. In accordance with the PPE-exposed mice, the two mucins (MUC5AC and MUC5B), AGR2, and FCGBP were all increased in COPD. Another known goblet cell product, trefoil factor 3 (TFF3) was found in both the human intestine and airways (Podolsky et al., 1993; Wiede et al., 1999) . In the airways DMBT1, a scaffolding protein involved in binding bacteria facilitating their removal, was also increased in COPD BALF (Madsen et al., 2010) . The prostate stem cell antigen (PSCA) was increased in COPD patients compared to asymptomatic and never smokers. Interestingly, PSCA has been suggested to act as a negative regulator of the α7 nicotinic acetylcholine receptors and by this inhibiting nicotinic signaling (Fu et al., 2015) , something that might be related to nicotine intake as all COPD patients were smokers. Increased amounts of transglutaminase 2 (TGM2) has previously been observed in COPD (Ohlmeier et al., 2016) , indicating that also lung mucins can be covalently crosslinked as observed in colon (Recktenwald and Hansson, 2016) .
Comparing the lung BALF proteome between humans and mice revealed some discrepancies probably related to species differences. The chitinase-like proteins were more abundant in mice. Still, the chitinase 3-like protein (CHI3L1) found in airway epithelial cells is a marker of human asthma severity and declined lung function (Komi et al., 2016) . The Clca1 protein, a typical colon mucus protein, was dramatically increased in the PPE-exposed mice, but not in human BALF. Clca1 was first suggested to be related to chloride ion channels, but more recent studies have shown that it is a protease that might be involved in mucus turnover (Lee et al., 2015) . The ZG16 protein produced by goblet cells is abundant in mouse and human colonic mucus where it protects the epithelial cells by aggregating gram-positive bacteria and by this translocating them further away from the epithelial cell surface (Bergström et al., 2016) . This protein is absent in the human BALF, but a similar protein named ZG16B, was highly increased in COPD patients. However, this protein was not present in mice.
Increased levels of the two gel-forming mucins MUC5AC and MUC5B are probably the most typical alteration in the human lung diseases chronic bronchitis, COPD, CF and asthma as well as in all animal models (Thornton et al., 2008) . This was also common for both the PPE mouse model and human COPD samples studied herein. This common feature is irrespective of the different organization of the normal mucus producing cells in mice and humans where the latter have submucosal glands that make long MUC5B bundles (Ermund et al., 2017) . In normal mice the surface goblet cells more or less only produce the Muc5b mucin, but there is a dramatic increase in the Muc5ac produced upon the induced goblet cell hyperplasia. The MUC5B mucin forms linear polymers responsible for normal clearing of the lungs in both species (Ridley et al., 2014) , whereas MUC5AC with its more complex polymers is typical for normal pig and human surface goblet cells and in all species more related to disease. The ratio of these two mucins are similar in BALF from the PPE mice and COPD suggesting that the composition of the accumulated mucus should be similar despite the large differences in normal lung of mice and men. In the mouse, more Muc5b mucin were concentrated to the mucus plugs and BALF washings of Muc5b/Muc5ac knock-out animals also suggested that Muc5b contributed most to mucus obstruction. This relative larger importance of Muc5b in mouse is also observed for normal lung clearance (Roy et al., 2014) . Even if we do not fully understand the details of how these two mucins contribute to mucus properties, it may suggest that the accumulated disease associated mucus has similar features in the two species.
The protein composition of the mucus accumulated in the PPE mice and COPD show large similarities to that of the inner colon mucus layer. Even more intriguing is that the structure of the accumulated mucus in COPD, CF and in the PPE-exposed mice show a striated arrangement closely resembling that of the inner mucus layer of normal colon (Johansson et al., 2008) . The way to observe mucus is to utilize Carnoy-fixation that better preserves the structure of the water-rich mucus. In colon, the inner mucus layer act as a barrier that physically separates the luminal bacteria from the epithelial surface (Johansson et al., 2008) . This separation is obtained by the MUC2 mucin forming net-like sheets that when layered on each other form a filter and thereby protect the epithelial cells. We now suggest that upon infection of the airways, the mucus which is normally easily moved by cilia, turns into an attached mucus layer resembling that in the normal colon, with similar components and structure. It is reasonable to believe that this airway mucus layer should act as in colon, i.e. as an innate defense mechanism aimed at keeping the bacteria away from the host epithelial cell surface.
Washing the PPE-exposed mice lungs with PBS partly removed the mucus plugs blocking especially the more peripheral airways. However, a similar proportion of the epithelial surface was covered by mucus without and after washing suggesting that the mucus was attached. Studies of tissue sections, also after intense washings, suggested that the mucus and the two mucins were anchored in the goblet cells. Interestingly, this is similar to what has been observed for mucus in the CF small intestine where the Muc2 mucin is not properly unfolded and thus not released from its attachment by the meprin β protease (Gustafsson et al., 2012; Schütte et al., 2014) . To test if the commonly used CF treatment, hypertonic saline, could further detach the attached mucus we treated the PPE-exposed mice two times with 7% NaCl. Hypertonic saline significantly decreased airway mucus obstruction better than PBS. However, this treatment was not better than PBS in removing the attached mucus that covered the epithelial surface. Together this makes it likely that the attachment of the mucus to the goblet cells is the main mechanism for obtaining an airway mucus layer.
The normal lung is kept relatively free of bacteria by the cilia mediated mucus escalator.
However, if this fails we now suggest that a second line of defense is triggered by the formation of an attached mucus layer, similar to the normal protection of the colon epithelium. The physiological function of this airway mucus layer might thus be to protect the epithelial cells.
This attached stratified mucus layer may be a normal physiological mechanism attempting to separate the bacteria from the epithelial cells to give the immune system a possibility to raise an immune response. Once the bacteria are under control, the mucus should be removed after detachment. However, this type of mucus will not be transported very efficiently by the cilia and probably has to be coughed up, a typical resolution to any lung infection. In chronic lung diseases like chronic bronchitis, COPD, CF and severe asthma, the mucus probably remains attached as shown here and although the epithelium is better protected, the bacteria retention will lead to lung deterioration. The intriguing question is now the molecular details regulating mucus attachment.
Materials and Methods
Animals.
Female C57BL/6N (Taconic), Muc5b hypertonic saline (7% NaCl) was tested to investigate the ability to detach airway mucus.
Blood cell count and inflammatory mediator analysis.
Total and differential white blood cell (WBC) counts were determined using an automated cell 
Mucus plug isolation.
For mucus plug isolation, BAL was performed with an Alcian blue solution in PBS. First, a 5%
wt/vol suspension of Alcian blue 8GX (Sigma-Aldrich) in PBS was prepared. After mixing overnight (1,000 rpm) in a Thermomixer comfort (Eppendorf) at room temperature, this was centrifuged (14,000 g, 10 min, room temperature). The supernatant was further diluted 1:40 in PBS. Mucus plugs, identified as Alcian blue-stained structures in BALF, were transferred with a 10 µl tip to a dry tube, frozen in liquid N 2 and stored at -80°C.
PPE inactivation.
To inactivate the serine peptidase activity of PPE, a stock solution of 50 units/ml was incubated (Fig S1) . The percentage of inhibition was calculated for the last reading.
Histopathological analysis.
After obtaining BALF, the thoracic cavity was opened. Lungs used to characterize inflammatory response and goblet cell hyperplasia were perfused through the interventricular septum with 10 ml PBS and then inflated to 25 cm H 2 O static pressure by intratracheal instillation of Carnoy (60% methanol dried, 30% chloroform stabilized with ethanol and 10% glacial acetic acid 100% anhydrous). The trachea was tied and the inflated lungs removed and immersed in fixative. Lungs used to study airway mucus accumulation and plugging were directly immersed in Carnoy, without previous inflation. Lungs were embedded in paraffin and sections (3 μm), comprising both the left and the right lung lobes, were cut at the level of the tracheobronchial tree. Sections were stained with H&E to evaluate inflammation and structural alterations, with Alcian blue/periodic acid-Schiff (AB/PAS) to assess goblet cell hyperplasia and mucus accumulation or used for immunostainings.
Quantification of mucus accumulation.
Images of mouse lung sections stained with AB/PAS were obtained at 100X magnification using 
Immunostainings.
Lung tissue sections were dewaxed, rehydrated and microwave antigen retrieval was performed Analysis of all data was performed in a blinded manner.
Transmission electron microscopy.
Mouse lungs were fixed in modified Karnovsky's fixative (2% paraformaldehyde, 2.5% glutaraldehyde in 0.05 M, sodium cacodylate buffer, pH 7.2) for 24 h. One lung lobe was divided into 9 transverse sections and every other section starting from the second section was processed further for electron microscopy. Samples were sequentially stained using 1% OsO 4 for 4 h, 1% tannic acid for 3 h and 1% uranyl acetate overnight then dehydrated and embedded in epoxy resin (Agar 100, Agar Scientific). Electron microscopy was conducted on 50 nm sections cut using an Ultracut E (Reichert) microtome and collected on mesh copper support grids. The sections were contrasted using lead citrate and tannic acid and images were acquired using a LEO 912 transmission electron microscope (Carl Zeiss) operated at an accelerating voltage of 120 kV.
Isolation of Epithelial Cells.
After obtaining BALF, lungs were washed twice through the intratracheal cannula with 0.8 ml PBS and the liquid discarded. Thereafter, epithelial cells were isolated using a predisgestion buffer (20 mM EDTA and 1 mM DTT in HBSS without Ca 2+ or Mg 2+ supplemented with 10 mM HEPES). Initially, 0.8 ml of pre-warmed predisgestion buffer was instilled through the intratracheal cannula. Lungs were immersed in pre-warmed PBS and placed in a water bath at 37°C, where they remained during the whole procedure. Lungs were then washed with 0.8 ml of pre-warmed predigestion buffer once at 15 and 30 min and 4 times at 45 min and 1 h after the first instillation, respectively. After each lavage, the buffer aspirated from the lungs containing epithelial cells in suspension was transferred to a tube kept on ice. All the lavages obtained from 3 animals belonging to the same group were pooled to obtain each epithelial cell sample. The cell suspension was vortexed for 2 min and centrifuged (500 g, 10 min, 4°C). The supernatant was discarded and the cell pellet resuspended in 2 ml HBSS and kept on ice. Erythrocytes were lysed using the ACK Lysing Buffer (Gibco, Thermo Fisher Scientific). Afterwards, cell pellets were incubated in 1 ml of collagenase type I (2mg/ml; 17100-017, Invitrogen) and DNAse I ( Table S7 ).
Peptides released from the filter by centrifugation were cleaned with StageTip C18 columns as previously described (Rappsilber et al., 2007) . Nano-Liquid-Chromatography Massspectrometry (NanoLC-MS/MS) was performed on an EASY-nLC system (Thermo Scientific), 
Patient samples.
BALF samples were collected from healthy non-smokers, healthy smokers, and patients with diagnosed COPD. The patients included are gathered in Table S5 Study approval.
Care and use of animals was undertaken in compliance with the European Community Directive 2010/63/EU. Animal experiments were approved by the local ethics committee in Gothenburg with the ethical permit numbers 100-2014 and 75-2015. Human samples were acquired with approval by the local human research ethics committee with the permit number 543-11. All human subjects gave written informed consent prior to inclusion and all investigations were performed in accordance with the Declaration of Helsinki.
Statistics.
Results are presented as median ± interquartile range, mean ± SEM. For comparing two independent groups, we used the Mann-Whitney U test and for comparison of multiple groups we used Kruskal-Wallis and Dunn's post-test to correct for multiple comparisons. The number of biological replicates is indicated by n number of animals or samples when several animals were pooled to obtain one data point. Significance was defined as P < 0.05.
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